Daratumumab therapy for post-HSCT immune-mediated cytopenia: experiences from two pediatric cases and review of literature

BACKGROUND: Immune-mediated cytopenias (AIC) are challenging complications following allogeneic hematopoietic stem cell transplantation (HSCT). While broad-acting immunosuppressive agents like corticosteroids are often standard of care, several novel therapies which target specific immunological pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Driouk, Lina, Schmitt, Robert, Peters, Anke, Heine, Sabine, Girschick, Hermann Josef, Strahm, Brigitte, Niemeyer, Charlotte M., Speckmann, Carsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Case Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085143/
https://www.ncbi.nlm.nih.gov/pubmed/33914175
http://dx.doi.org/10.1186/s40348-021-00114-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085143/
https://www.ncbi.nlm.nih.gov/pubmed/33914175
http://dx.doi.org/10.1186/s40348-021-00114-y

Ejemplares similares